Literature DB >> 30983519

LncRNA FENDRR represses proliferation, migration and invasion through suppression of survivin in cholangiocarcinoma cells.

Xinglei Qin1, Min Lu2, Yajun Zhou1, Gang Li1, Zhaoyang Liu1.   

Abstract

This study was to investigate the biological function and underlying mechanisms of FENDRR in cholangiocarcinoma (CCA) cell proliferation, migration and invasion. FENDRR and survivin expression in CCA tissues or cell lines were measured by qRT-PCR. In QBC939 and HuCCTl cells, cell proliferation was detected by CCK-8, cell migration and invasion were using transwell assay. RNA pull-down and RIP assay were performed to determine whether FENDRR can combine with SETDB1 in CCA cell. The effect of SETDB1 on survivin and H3K9me1 expression in CCA cells were determined by western blotting. ChIP analysis was performed to analyze the combination of SETDB1 with survivin promoter in CCA cell. The effect of SETDB1 knockdown on survivin and H3K9me1 expression in CCA cells after transfection with FENDRR were determined by western blotting. The results showed that lncRNA FENDRR was downregulated in CCA tissues and cells, and was negatively correlated with survivin expression. Further investigation demonstrated that FENDRR represses CCA cell proliferation, migration and invasion through regulating survivin expression. FENDRR associated with SETDB1 and H3K9 to epigenetically silence survivin and then regulated cell proliferation, migration and invasion. These findings indicate an important role for FENDRR-survivin axis in CCA cell proliferation, migration and invasion, and reveal a novel epigenetic mechanism for survivin silencing. Our data indicated that FENDRR silences survivin via SETDB1-mediated H3K9 methylation, thereby represses CCA cell proliferation, migration and invasion.

Entities:  

Keywords:  LncRNA FENDRR; cholangiocarcinoma; proliferation; survivin

Mesh:

Substances:

Year:  2019        PMID: 30983519      PMCID: PMC6527288          DOI: 10.1080/15384101.2019.1598726

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  28 in total

Review 1.  Genome regulation by long noncoding RNAs.

Authors:  John L Rinn; Howard Y Chang
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

2.  Tanshinone I induces human colorectal cancer cell apoptosis: The potential roles of Aurora A-p53 and survivin-mediated signaling pathways.

Authors:  Mingjie Lu; Chen Wang; Jian Wang
Journal:  Int J Oncol       Date:  2016-06-07       Impact factor: 5.650

3.  Leptin-STAT3-G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression.

Authors:  Chao-Ching Chang; Meng-Ju Wu; Jer-Yen Yang; Ignacio G Camarillo; Chun-Ju Chang
Journal:  Cancer Res       Date:  2015-04-03       Impact factor: 12.701

Review 4.  Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma.

Authors:  Steven Koprowski; Kevin Sokolowski; Selvi Kunnimalaiyaan; T Clark Gamblin; Muthusamy Kunnimalaiyaan
Journal:  J Surg Res       Date:  2015-03-19       Impact factor: 2.192

5.  MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.

Authors:  Jiajun Zhang; Sheng Wang; Feng Han; Jian Li; Lan Yu; Ping Zhou; Zhijun Chen; Sheng Xue; Changyuan Dai; Qingwen Li
Journal:  Gene       Date:  2015-12-23       Impact factor: 3.688

6.  Guggulsterone inhibits human cholangiocarcinoma Sk-ChA-1 and Mz-ChA-1 cell growth by inducing caspase-dependent apoptosis and downregulation of survivin and Bcl-2 expression.

Authors:  Fei Zhong; Jing Yang; Zhu-Ting Tong; Liu-Liu Chen; Lu-Lu Fan; Fang Wang; Xia-Li Zha; Jun Li
Journal:  Oncol Lett       Date:  2015-06-19       Impact factor: 2.967

Review 7.  Targeting survivin in cancer therapy: fulfilled promises and open questions.

Authors:  Marzia Pennati; Marco Folini; Nadia Zaffaroni
Journal:  Carcinogenesis       Date:  2007-03-06       Impact factor: 4.944

8.  miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.

Authors:  Rong Yang; Minghui Liu; Hongwei Liang; Suhan Guo; Xu Guo; Min Yuan; Huibo Lian; Xiang Yan; Shiwei Zhang; Xi Chen; Feng Fang; Hongqian Guo; Chenyu Zhang
Journal:  Mol Cancer       Date:  2016-12-15       Impact factor: 27.401

9.  Long non-coding RNA FENDRR inhibits cell proliferation and is associated with good prognosis in breast cancer.

Authors:  Yan Li; Wenwen Zhang; Pengying Liu; Yumei Xu; Lin Tang; Weiwei Chen; Xiaoxiang Guan
Journal:  Onco Targets Ther       Date:  2018-03-14       Impact factor: 4.147

10.  Setdb1, a novel interactor of ΔNp63, is involved in breast tumorigenesis.

Authors:  Carla Regina; Mirco Compagnone; Angelo Peschiaroli; AnnaMaria Lena; Margherita Annicchiarico-Petruzzelli; Maria Cristina Piro; Gerry Melino; Eleonora Candi
Journal:  Oncotarget       Date:  2016-05-17
View more
  8 in total

1.  Mitochondrial Homeostasis-Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma.

Authors:  Bo Peng; Han Lou; Chen Chen; Lei Wang; Huawei Li; Tong Lu; Ruisi Na; Ran Xu; Tong Xin; Lingqi Yao; Henghui Xu; Kaiyu Wang; Xin Liu; Linyou Zhang
Journal:  Front Genet       Date:  2022-06-13       Impact factor: 4.772

2.  The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor Prognosis.

Authors:  Hao Liu; Zhe Zhang; Yanan Han; Ahui Fan; Haiming Liu; Xiangyuan Zhang; Yanhong Liu; Rugang Zhang; Wanning Liu; Yuanyuan Lu; Daiming Fan; Xiaodi Zhao; Yongzhan Nie
Journal:  Front Oncol       Date:  2021-03-22       Impact factor: 6.244

3.  LncRNA FENDRR Inhibits ox-LDL Induced Mitochondrial Energy Metabolism Disorder in Aortic Endothelial Cells via miR-18a-5p/PGC-1α Signaling Pathway.

Authors:  Guiming Wang; Yudong Yang; Honggang Ma; Liuming Shi; Wenbin Jia; Xing Hao; Weizong Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-12       Impact factor: 5.555

Review 4.  Long Non-Coding RNAs in Biliary Tract Cancer-An Up-to-Date Review.

Authors:  Dino Bekric; Daniel Neureiter; Markus Ritter; Martin Jakab; Martin Gaisberger; Martin Pichler; Tobias Kiesslich; Christian Mayr
Journal:  J Clin Med       Date:  2020-04-22       Impact factor: 4.241

5.  FENDRR suppresses cervical cancer proliferation and invasion by targeting miR-15a/b-5p and regulating TUBA1A expression.

Authors:  Yunheng Zhu; Xiaohua Zhang; Lifeng Wang; Xiuxiang Zhu; Ziyin Xia; Ling Xu; Jun Xu
Journal:  Cancer Cell Int       Date:  2020-05-06       Impact factor: 5.722

Review 6.  Concise Review: Functional Roles and Therapeutic Potentials of Long Non-coding RNAs in Cholangiopathies.

Authors:  Keisaku Sato; Shannon Glaser; Heather Francis; Gianfranco Alpini
Journal:  Front Med (Lausanne)       Date:  2020-02-20

Review 7.  Emerging roles of long noncoding RNAs in cholangiocarcinoma: Advances and challenges.

Authors:  Yang Yang; Xueting Deng; Quanpeng Li; Fei Wang; Lin Miao; Qi Jiang
Journal:  Cancer Commun (Lond)       Date:  2020-11-03

8.  LncRNA Nuclear-Enriched Abundant Transcript 1 Regulates Atrial Fibrosis via the miR-320/NPAS2 Axis in Atrial Fibrillation.

Authors:  Huangdong Dai; Naishi Zhao; Hua Liu; Yue Zheng; Liang Zhao
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.